Get an alert when ALCON EYE CARE UK LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-05-10 (in 1y)

Last made up 2026-04-26

Watchouts

None on the register

Cash

£4M

-39.3% vs 2023

Net assets

£53M

+11.6% highest in 4 filed years

Employees

210

-2.3% vs 2023

Profit before tax

£8M

-1.1% vs 2023

Name history

Renamed 2 times since incorporation

  1. ALCON EYE CARE UK LIMITED 2012-08-01 → present
  2. CIBAVISION (U.K.) LIMITED 1988-12-22 → 2012-08-01
  3. CONTACTASOL LIMITED 1964-06-16 → 1988-12-22

Accounts

4-year trend · latest reflected 2024-12-31

Metric Trend 2021-12-312022-12-312023-12-312024-12-31
Turnover £139,093£151,038£166,373,000£172,168,000
Operating profit £3,442£9,262£8,155,000£7,958,000
Profit before tax £3,074£8,830£7,669,000£7,588,000
Net profit £4,694,000£5,681,000
Cash £283£12,486£6,383,000£3,876,000
Total assets less current liabilities £63,898£61,867£62,012,000£67,276,000
Net assets £45,105£43,703£47,221,000£52,682,000
Equity £45,105£43,703£47,221,000£52,682,000
Average employees 201211215210
Wages £17,773,000£18,409,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2021-12-312022-12-312023-12-312024-12-31
Operating margin 2.5%6.1%4.9%4.6%
Net margin 2.8%3.3%
Return on capital employed 5.4%15.0%13.2%11.8%
Current ratio 2.82x3.25x
Interest cover 8.29x19.34x8.75x13.09x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
PricewaterhouseCoopers LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The financial statements have been prepared on the going concern basis as the Directors have a reasonable expectation that the Company has adequate resources for a period of at least 12 months from the date of the approval of the financial statements and that there are no material uncertainties to disclose.”

Group structure

  1. ALCON EYE CARE UK LIMITED · parent
    1. Alcon Laboratories (U.K.) Limited 100% · Great Britain · Trading

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 49 resigned

Name Role Appointed Born Nationality
WESTON, Rebecca Secretary 2021-01-21
HENRY, Roy Lindsay Allen Director 2019-04-09 Aug 1968 British
KOSTETSKAYA, Olga Director 2024-04-12 Sep 1971 Ukrainian
ROMEU, Xavier Director 2020-07-06 Dec 1964 French
Show 49 resigned officers
Name Role Appointed Resigned
HENRY, Roy Lindsay Allen Secretary 2017-06-22 2018-06-14
HOUSDEN, John Eric, Dr Secretary 1995-05-01 1997-06-30
JENNINGS, Sally Jane Secretary 2001-01-23 2008-03-11
KAYA, Sinan Secretary 2020-07-06 2021-01-21
KHOO, Cheryl Tsu Lynn Secretary 2018-06-14 2020-05-31
MAXTED, Nicola Karen Secretary 2010-06-18 2017-06-22
ROBERTS, Helen Secretary 2008-03-11 2010-06-18
THIRKETTLE, Paul Richard Edward Secretary 1997-06-30 2001-01-23
TINKER, David Timothy Secretary 1995-04-29
ADAMS, Adrian Director 2001-01-23 2001-06-08
AHMAD, Haseeb Director 2017-03-08 2019-04-09
ARROCHA, Edgar Humberto Director 2014-08-26 2016-08-15
ASHTON, David Thomas Director 2001-01-23 2001-09-27
ATTIAS, Laurent Director 2012-05-24 2013-02-12
BARNES, Howard Director 2004-10-14 2008-09-30
BARNETT, Terence Anthony Director 1996-04-06 1997-06-30
BELL, Ian Howard Director 2016-04-19 2019-04-09
BOURDAGE, Pierre Richard Director 2015-12-17 2018-06-14
BRAZIER, Richard John Director 2006-02-22 2009-07-01
CARLEN, Roland Director 2004-02-06 2005-01-01
COLOMBO, Franco Director 2019-04-09 2020-07-06
COOK, Chantelle Director 2020-07-06 2021-10-01
CUMMINS, Gordon John Director 2004-05-20 2006-02-01
FAHEY, Michael John Director 2001-12-04 2004-04-20
FRASER, John Stewart Director 1996-03-31
FULLAGAR, Edgar Director 1997-06-30 2002-04-23
GOWER ISAAC, Harriet Director 2019-04-09 2020-07-06
HAMMOND, Daniel Director 2004-04-21 2004-10-14
HOUSDEN, John Eric, Dr Director 1995-05-01 1999-04-14
HOUSDEN, John Eric, Dr Director 1992-06-28 1993-03-04
JOSE, Teresa Director 2009-07-01 2012-03-06
KAPADIA, Sandipkumar Shantilal Director 2012-03-06 2014-08-26
KOHOUT, Susanne Maria Director 2007-05-22 2012-05-24
KORANGY, Shervin Joe Director 2014-06-16 2015-12-17
KUDELKA, Jurgen Director 1998-10-06 2004-02-06
LACAZE, Oriane Fanny Director 2016-08-15 2019-04-09
LOPEZ, Roger Director 2008-11-05 2014-06-16
O'DOWD, Hugh Michael Director 2015-10-15 2016-09-16
PARIS, William Drummond Director 2001-09-14 2005-04-22
RAETZMAN, Stuart Colin Director 2013-02-12 2014-03-19
SAIA, Andrea Lynn Director 2005-01-01 2007-05-22
SAXENA, Subhanu Director 2005-04-20 2009-08-26
SHERIF, Riad Director 2014-06-04 2016-04-19
STROPPEL, Stefan Hans Director 1998-01-19 2001-01-23
SWALWELL, Marcus Charles Director 1999-04-14 2004-04-21
TERRELL, Robin Guy Director 1998-10-06
TRIMMING, Julian William Director 1995-02-21
TURNER, Michael Christopher Director 2021-10-01 2024-02-29
WEBB, Susan Ann Director 2009-08-26 2015-09-01

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Alcon Inc. Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2018-12-12 Active
Novartis Ag Corporate entity Shares 50–75%, Voting 50–75%, Appoints directors 2016-04-06 Ceased 2018-12-12

Filing timeline

Last 20 of 241 total filings

Date Type Category Description
2026-05-05 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-08-21 AA accounts Accounts with accounts type full
2025-05-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-08-22 AA accounts Accounts with accounts type full
2024-04-26 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-04-19 AP01 officers Appoint person director company with name date PDF
2024-04-18 TM01 officers Termination director company with name termination date PDF
2023-08-16 AAMD accounts Accounts amended with accounts type full
2023-06-12 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-06-12 AA accounts Accounts with accounts type total exemption full PDF
2023-02-17 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-10-05 AA accounts Accounts with accounts type full
2022-04-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-10-26 TM01 officers Termination director company with name termination date PDF
2021-10-26 AP01 officers Appoint person director company with name date PDF
2021-09-28 AA accounts Accounts with accounts type full
2021-08-17 CS01 confirmation-statement Confirmation statement with updates PDF
2021-02-02 AP03 officers Appoint person secretary company with name date PDF
2021-01-29 TM02 officers Termination secretary company with name termination date PDF
2020-12-10 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
3

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers

Official Companies House page